Results 31 to 40 of about 10,121,822 (165)
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Antea Group Archeologie 2020/75
Antea Group projectnummer 412729 In mei 2020 heeft Antea Group in opdracht van de opdrachtgever een archeologisch onderzoek uitgevoerd voor het plangebied ‘T020_08_AN’ te Bergen op Zoom, gemeente Bergen op Zoom.
Jong, M. de (Antea Group)
core +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Antea Group Archeologie 2019/67
Antea Group projectnummer 432648 ARCHIS zaaknummer 4697972100 Antea Group heeft in april 2019 een archeologisch bureauonderzoek uitgevoerd voor de aanleg van een warmteleiding ten noorden van De Lier in de gemeente Westland.
Colijn, J.E. (Antea Group)
core +1 more source
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman +9 more
wiley +1 more source
Antea Group Archeologie 2018/153
In september 2018 heeft Antea Group in opdracht van CroonenBuro5 een archeologisch booronderzoek (verkennende fase) uitgevoerd voor een plangebied dat valt binnen het grotere bestemmingsplan Slotjes te Oosterhout. Het plangebied bestaat uit verschillende
Arkema, Drs. M. (Antea Group) +45 more
core +1 more source
Antea Group Archeologie 2020/216
Antea Group 460906. Op 5 en 6 november 2020 heeft Antea Group een opgraving – variant archeologische begeleiding uitgevoerd op een locatie langs de Oude Roodehaansterweg in Groningen.
Bosgraaf, G.B (Antea Group)
core +1 more source
ABSTRACT Background Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.
Karen Schow Jensen +10 more
wiley +1 more source
ABSTRACT Pediatric intramedullary low‐grade gliomas (PIMLGGs) are rare neoplasms that present unique clinical and management challenges. Although surgery remains the primary tool for tissue diagnosis and decompression, complete gross‐total resection is frequently unfeasible due to the infiltrative nature of these lesions.
Olga M. Sergeenko +5 more
wiley +1 more source

